Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites (Q37349299)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 May 2009
edit
Language Label Description Also known as
English
Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites
scientific article published on 26 May 2009

    Statements

    Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit